Revolution Medicines, Inc. is 10.1x more valuable than Beam Therapeutics Inc. by market capitalization ($30.74 B vs $3.03 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | BEAM | RVMD |
|---|---|---|
| Market cap | $3.03 B | $30.74 B |
| US-listed rank | #1807 | #453 |
| Revenue (latest FY) | $139.74M | $0.00 |
| Net income (latest FY) | -$79.99M | -$1.13B |
| Net margin | -57.2% | - |
| SEC filings | 488 | 782 |
Revolution Medicines, Inc. is 10.1x more valuable than Beam Therapeutics Inc. by market capitalization ($30.74 B vs $3.03 B).
In their latest fiscal years, Beam Therapeutics Inc. reported $139.74M in revenue while Revolution Medicines, Inc. reported $0.00.
Full pages: Beam Therapeutics Inc. and Revolution Medicines, Inc., or browse the full rankings.